Back

Percutaneous transluminal alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy and drug refractory symptoms: intermediate-term outcomes of a prospective cohort.

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Non-coronary cardiac interventions Noncoronary Cardiac Intervention, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Ms Maria Plaza Martin

UNIVERSITY HOSPITAL CLINIC, Valladolid (Spain)

13 More presentations in this session

Presentation thumbnail
Doctor F. Fioravanti (Milan, IT)
Abstract
Presentation thumbnail
Doctor T. Pommier (Dijon, FR)
Abstract Slides
Presentation thumbnail
Assistant Professor B. Al-Kassou (Bonn, DE)
Abstract Slides
Presentation thumbnail
Doctor P. Brennan (Belfast, GB)
Abstract Slides
Presentation thumbnail
Professor V. Veulemans (Duesseldorf, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Non-coronary cardiac interventions

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources